Fasoracetam: What the Research Shows
A research-audience overview of Fasoracetam, a racetam-class nootropic compound studied in laboratory glutamate-receptor models. Research use only.
Read articleB7-33: What the Research Shows
Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and B7-33 is not approved for human or veterinary use.
What is B7-33?
B7-33 is a single-chain peptide derived from the hormone relaxin (specifically relaxin-2). It was designed as a simplified functional analogue and is studied in the research literature for its interaction with the relaxin receptor and anti-fibrotic pathways.
Where B7-33 sits in the research literature
The evidence base is preclinical, based on cell and animal studies of fibrosis-related pathways. Laboratory findings should not be extrapolated to people.
Reported areas of preclinical interest
- Relaxin receptor (RXFP1): studied for signalling at the relaxin receptor in laboratory models.
- Anti-fibrotic pathways: examined for effects on tissue-fibrosis models in research.
Why the “research use only” label matters
B7-33 is supplied as a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.
Handling and storage
Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.
Frequently asked questions
What is B7-33 studied for?
It is studied as a single-chain relaxin analogue at the relaxin receptor and in anti-fibrotic pathways in laboratory models.
Is B7-33 approved for human use?
No. It is a research material only and is not intended for human or veterinary use.
Key takeaways
B7-33 is a single-chain relaxin peptide analogue studied in preclinical fibrosis and receptor research. It is a research material only. Review the B7-33 research product.
References
- Relaxin and B7-33 literature. PubMed.
Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.
Keep reading
Tesofensine: What the Research Shows
A research-audience overview of Tesofensine, a triple monoamine reuptake inhibitor studied in laboratory neuropharmacology and metabolic models. Research use only.
Read article
Cartalax: What the Research Shows
A research-audience overview of Cartalax, a short peptide bioregulator studied in laboratory connective-tissue models. Research use only.
Read article